These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19013186)

  • 1. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited.
    Morris DJ; Latif SA; Brem AS
    Steroids; 2009 Jan; 74(1):1-6. PubMed ID: 19013186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases.
    Diederich S; Scholz T; Eigendorff E; Bumke-Vogt Ch; Quinkler M; Exner P; Pfeiffer AF; Oelkers W; Bähr V
    Horm Metab Res; 2004 Jun; 36(6):423-9. PubMed ID: 15241735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells.
    Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Takahashi N; Yoshida H
    Nephrol Dial Transplant; 2009 Jun; 24(6):1759-65. PubMed ID: 19153071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues.
    Morris DJ; Souness GW; Brem AS; Oblin ME
    Kidney Int; 2000 Apr; 57(4):1370-3. PubMed ID: 10760069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.
    Gaeggeler HP; Gonzalez-Rodriguez E; Jaeger NF; Loffing-Cueni D; Norregaard R; Loffing J; Horisberger JD; Rossier BC
    J Am Soc Nephrol; 2005 Apr; 16(4):878-91. PubMed ID: 15743993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect of corticosteroids along the distal tubule.
    Ackermann D; Gresko N; Carrel M; Loffing-Cueni D; Habermehl D; Gomez-Sanchez C; Rossier BC; Loffing J
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1473-85. PubMed ID: 20861076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
    Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
    Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone enhances 11beta-hydroxysteroid dehydrogenase type 2 expression in colonic epithelial cells in vivo.
    Fukushima K; Funayama Y; Yonezawa H; Takahashi K; Haneda S; Suzuki T; Sasano H; Naito H; Shibata C; Krozowski ZS; Sasaki I
    Scand J Gastroenterol; 2005 Jul; 40(7):850-7. PubMed ID: 16109662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of the antiproliferative effect of glucocorticosteroids by 11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cells.
    Lipka C; Mankertz J; Fromm M; Lübbert H; Bühler H; Kühn W; Ragosch V; Hundertmark S
    Horm Metab Res; 2004 Jul; 36(7):437-44. PubMed ID: 15305225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptors: emerging complexity and functional diversity.
    Odermatt A; Atanasov AG
    Steroids; 2009 Feb; 74(2):163-71. PubMed ID: 19022273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
    Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
    Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol resistance in conditions such as asthma and the involvement of 11beta-HSD-2: a hypothesis.
    Pretorius E; Wallner B; Marx J
    Horm Metab Res; 2006 Jun; 38(6):368-76. PubMed ID: 16823718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal gland involvement in the regulation of renal 11beta-hydroxysteroid dehydrogenase 2.
    Zallocchi ML; Matkovic L; Calvo JC; Damasco MC
    J Cell Biochem; 2004 Jun; 92(3):591-602. PubMed ID: 15156570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2.
    Gong R; Morris DJ; Brem AS
    Life Sci; 2008 Mar; 82(11-12):631-7. PubMed ID: 18261751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptors: distribution and activation.
    Funder JW
    Heart Fail Rev; 2005 Jan; 10(1):15-22. PubMed ID: 15947887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
    Bistrup C; Thiesson HC; Jensen BL; Skøtt O
    Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa.
    Kato K; Sasano H; Ohara S; Sekine H; Mochizuki S; Mune T; Yasuda K; Nagura H; Shimosegawa T; Toyota T; Krozowski Z
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2568-73. PubMed ID: 10404838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine vasopressin stimulates 11beta-hydroxysteroid dehydrogenase type 2 expression in the mineralocorticosteroid target cells.
    Rubis B; Krozowski Z; Trzeciak WH
    Mol Cell Endocrinol; 2006 Aug; 256(1-2):17-22. PubMed ID: 16872738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
    Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
    J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.